A Study of the Changes in Nutrition Status of Patients with Acute Myeloid Leukemia


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-009466
    Sponsor Protocol Number: 16-009466

About this study

The purpose of this study is to determine best practices for the assessment and timing of nutrition interventions in patients who have Acute Myeloid Leukemia (AML).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Adult (≥ 18)
  • Hem 2 service
  • Diagnosis of acute myeloid leukemia (AML)
  • Can understand spoken and written English

Exclusion Criteria 

  • Pediatric patients (<18)
  • Diagnosis other than acute myeloid leukemia (AML)
  • Cannot read and understand English

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joy Heimgartner, M.S., RDN, LD

Contact us for the latest status

Contact information:

Joy Heimgartner M.S., RDN, LD


Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions